Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04251533
What this trial is testing

Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss

Who this might be right for
Triple Negative Breast Neoplasms
Novartis Pharmaceuticals 137
Testing effectiveness (Phase 2)Looking for participantsNCT07638852
What this trial is testing

Study of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of TNBC-BM.

Who this might be right for
TNBC, Triple Negative Breast CancerBrain Metastasases
Fudan University 58
Testing effectiveness (Phase 2)Looking for participantsNCT05985655
What this trial is testing

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Pancreatic AdenocarcinomaNon-small Cell Lung Cancer (NSCLC)+3 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 230
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07509515
What this trial is testing

QLC5513 Alone or in Combination With QL1706 in Previously Treated Advanced or Metastatic TNBC.

Who this might be right for
Triple-negative Breast Cancer (TNBC)
Fudan University 60
Early research (Phase 1)Looking for participantsNCT06324240
What this trial is testing

Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+24 more
Emory University 18
Not applicableLooking for participantsNCT06582615
What this trial is testing

Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Triple-Negative Breast Carcinoma
Ohio State University Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT06817525
What this trial is testing

Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC

Who this might be right for
Triple-negative Breast Cancer
Henan Cancer Hospital 64
Testing effectiveness (Phase 2)WithdrawnNCT06084689
What this trial is testing

Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures

Who this might be right for
Adult Soft Tissue SarcomaNon Small Cell Lung CancerTriple Negative Breast Cancer+2 more
Institut Bergonié
Large-scale testing (Phase 3)Looking for participantsNCT05862064
What this trial is testing

A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 606
Not applicableUnknownNCT02670668
What this trial is testing

Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 100
Early research (Phase 1)Study completedNCT05390710
What this trial is testing

PhI to Solid Tumors and PhII to Locally Advanced or mTNBC

Who this might be right for
Solid TumorTNBC - Triple-Negative Breast Cancer
Laekna Limited 21
Testing effectiveness (Phase 2)Looking for participantsNCT06353997
What this trial is testing

Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients

Who this might be right for
Triple Negative Breast Cancer
Providence Health & Services 12
Testing effectiveness (Phase 2)UnknownNCT05103917
What this trial is testing

Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC

Who this might be right for
Triple Negative Breast Cancer
Abbisko Therapeutics Co, Ltd 24
Testing effectiveness (Phase 2)Study completedNCT03301350
What this trial is testing

Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer
University of Wisconsin, Madison 29
Post-approval studies (Phase 4)Not Yet RecruitingNCT05843292
What this trial is testing

Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Shanghai Jiao Tong University School of Medicine 48
Not applicableStudy completedNCT02158507
What this trial is testing

Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer

Who this might be right for
Metastatic Triple Negative Breast Cancer
University of Alabama at Birmingham 20
Testing effectiveness (Phase 2)Looking for participantsNCT05579366
What this trial is testing

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Who this might be right for
High Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more
Genmab 884
Testing effectiveness (Phase 2)Active Not RecruitingNCT04373031
What this trial is testing

Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer

Who this might be right for
Breast CancerBreast Neoplasms
Providence Health & Services 12
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Testing effectiveness (Phase 2)Looking for participantsNCT05660083
What this trial is testing

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

Who this might be right for
HER2-negative Breast CancerMetastatic Breast CancerMetaplastic Breast Carcinoma+1 more
The Methodist Hospital Research Institute 36
Next Page